USA Monoclonal Antibody Therapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Monoclonal Antibody Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Monoclonal Antibody Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Monoclonal Antibody Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sanofi

    • AbbVie Inc

    • Merck KGaA

    • Amgen Inc

    • F Hoffmann-La Roche Ltd

    • GlaxoSmithKline Plc

    • Bristol – Myers Squibb Company

    • Sigma-Aldrich Co LLC

    • Novartis AG

    • GenScript

    • Johnson & Johnson

    • Biogen Inc

    • Pfizer Inc

    • Bayer AG

    By Type:

    • Recombinant

    • Chimeric

    • Humanized

    • Human

    By End-User:

    • Diagnostic Test

    • Analytical and Chemical Uses

    • Cancer Treatment

    • Autoimmune Diseases

    • Hematological Disorders

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal Antibody Therapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Recombinant from 2016 to 2027

      • 1.3.2 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Chimeric from 2016 to 2027

      • 1.3.3 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Humanized from 2016 to 2027

      • 1.3.4 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Human from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Diagnostic Test from 2016 to 2027

      • 1.4.2 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Analytical and Chemical Uses from 2016 to 2027

      • 1.4.3 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Cancer Treatment from 2016 to 2027

      • 1.4.4 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

      • 1.4.5 USA Monoclonal Antibody Therapy Market Size and Growth Rate of Hematological Disorders from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Monoclonal Antibody Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Monoclonal Antibody Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Recombinant

      • 3.4.2 Market Size and Growth Rate of Chimeric

      • 3.4.3 Market Size and Growth Rate of Humanized

      • 3.4.4 Market Size and Growth Rate of Human

    4 Segmentation of Monoclonal Antibody Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Monoclonal Antibody Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Monoclonal Antibody Therapy in Diagnostic Test

      • 4.4.2 Market Size and Growth Rate of Monoclonal Antibody Therapy in Analytical and Chemical Uses

      • 4.4.3 Market Size and Growth Rate of Monoclonal Antibody Therapy in Cancer Treatment

      • 4.4.4 Market Size and Growth Rate of Monoclonal Antibody Therapy in Autoimmune Diseases

      • 4.4.5 Market Size and Growth Rate of Monoclonal Antibody Therapy in Hematological Disorders

    5 Market Analysis by Regions

    • 5.1 USA Monoclonal Antibody Therapy Production Analysis by Regions

    • 5.2 USA Monoclonal Antibody Therapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Monoclonal Antibody Therapy Landscape Analysis

    • 6.1 West USA Monoclonal Antibody Therapy Landscape Analysis by Major Types

    • 6.2 West USA Monoclonal Antibody Therapy Landscape Analysis by Major End-Users

    7 South USA Monoclonal Antibody Therapy Landscape Analysis

    • 7.1 South USA Monoclonal Antibody Therapy Landscape Analysis by Major Types

    • 7.2 South USA Monoclonal Antibody Therapy Landscape Analysis by Major End-Users

    8 Middle West USA Monoclonal Antibody Therapy Landscape Analysis

    • 8.1 Middle West USA Monoclonal Antibody Therapy Landscape Analysis by Major Types

    • 8.2 Middle West USA Monoclonal Antibody Therapy Landscape Analysis by Major End-Users

    9 Northeast USA Monoclonal Antibody Therapy Landscape Analysis

    • 9.1 Northeast USA Monoclonal Antibody Therapy Landscape Analysis by Major Types

    • 9.2 Northeast USA Monoclonal Antibody Therapy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Sanofi

        • 10.1.1 Sanofi Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 AbbVie Inc

        • 10.2.1 AbbVie Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Merck KGaA

        • 10.3.1 Merck KGaA Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Amgen Inc

        • 10.4.1 Amgen Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 F Hoffmann-La Roche Ltd

        • 10.5.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 GlaxoSmithKline Plc

        • 10.6.1 GlaxoSmithKline Plc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Bristol – Myers Squibb Company

        • 10.7.1 Bristol – Myers Squibb Company Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sigma-Aldrich Co LLC

        • 10.8.1 Sigma-Aldrich Co LLC Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Novartis AG

        • 10.9.1 Novartis AG Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 GenScript

        • 10.10.1 GenScript Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Johnson & Johnson

        • 10.11.1 Johnson & Johnson Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Biogen Inc

        • 10.12.1 Biogen Inc Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Pfizer Inc

        • 10.13.1 Pfizer Inc Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Bayer AG

        • 10.14.1 Bayer AG Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Recombinant from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Chimeric from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Humanized from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Human from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Diagnostic Test from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Analytical and Chemical Uses from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Cancer Treatment from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

    • Figure USA Monoclonal Antibody Therapy Market Size and Growth Rate of Hematological Disorders from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Monoclonal Antibody Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Monoclonal Antibody Therapy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Monoclonal Antibody Therapy by Different Types from 2016 to 2027

    • Table Consumption Share of Monoclonal Antibody Therapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Recombinant

    • Figure Market Size and Growth Rate of Chimeric

    • Figure Market Size and Growth Rate of Humanized

    • Figure Market Size and Growth Rate of Human

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Monoclonal Antibody Therapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Monoclonal Antibody Therapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Diagnostic Test

    • Figure Market Size and Growth Rate of Analytical and Chemical Uses

    • Figure Market Size and Growth Rate of Cancer Treatment

    • Figure Market Size and Growth Rate of Autoimmune Diseases

    • Figure Market Size and Growth Rate of Hematological Disorders

    • Table USA Monoclonal Antibody Therapy Production by Regions

    • Table USA Monoclonal Antibody Therapy Production Share by Regions

    • Figure USA Monoclonal Antibody Therapy Production Share by Regions in 2016

    • Figure USA Monoclonal Antibody Therapy Production Share by Regions in 2021

    • Figure USA Monoclonal Antibody Therapy Production Share by Regions in 2027

    • Table USA Monoclonal Antibody Therapy Consumption by Regions

    • Table USA Monoclonal Antibody Therapy Consumption Share by Regions

    • Figure USA Monoclonal Antibody Therapy Consumption Share by Regions in 2016

    • Figure USA Monoclonal Antibody Therapy Consumption Share by Regions in 2021

    • Figure USA Monoclonal Antibody Therapy Consumption Share by Regions in 2027

    • Table West USA Monoclonal Antibody Therapy Consumption by Types from 2016 to 2027

    • Table West USA Monoclonal Antibody Therapy Consumption Share by Types from 2016 to 2027

    • Figure West USA Monoclonal Antibody Therapy Consumption Share by Types in 2016

    • Figure West USA Monoclonal Antibody Therapy Consumption Share by Types in 2021

    • Figure West USA Monoclonal Antibody Therapy Consumption Share by Types in 2027

    • Table West USA Monoclonal Antibody Therapy Consumption by End-Users from 2016 to 2027

    • Table West USA Monoclonal Antibody Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2016

    • Figure West USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2021

    • Figure West USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2027

    • Table South USA Monoclonal Antibody Therapy Consumption by Types from 2016 to 2027

    • Table South USA Monoclonal Antibody Therapy Consumption Share by Types from 2016 to 2027

    • Figure South USA Monoclonal Antibody Therapy Consumption Share by Types in 2016

    • Figure South USA Monoclonal Antibody Therapy Consumption Share by Types in 2021

    • Figure South USA Monoclonal Antibody Therapy Consumption Share by Types in 2027

    • Table South USA Monoclonal Antibody Therapy Consumption by End-Users from 2016 to 2027

    • Table South USA Monoclonal Antibody Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2016

    • Figure South USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2021

    • Figure South USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2027

    • Table Middle West USA Monoclonal Antibody Therapy Consumption by Types from 2016 to 2027

    • Table Middle West USA Monoclonal Antibody Therapy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Share by Types in 2016

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Share by Types in 2021

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Share by Types in 2027

    • Table Middle West USA Monoclonal Antibody Therapy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Monoclonal Antibody Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2016

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2021

    • Figure Middle West USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2027

    • Table Northeast USA Monoclonal Antibody Therapy Consumption by Types from 2016 to 2027

    • Table Northeast USA Monoclonal Antibody Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Share by Types in 2016

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Share by Types in 2021

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Share by Types in 2027

    • Table Northeast USA Monoclonal Antibody Therapy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Monoclonal Antibody Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2016

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2021

    • Figure Northeast USA Monoclonal Antibody Therapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of AbbVie Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc

    • Figure Sales and Growth Rate Analysis of AbbVie Inc

    • Figure Revenue and Market Share Analysis of AbbVie Inc

    • Table Product and Service Introduction of AbbVie Inc

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Bristol – Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol – Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol – Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol – Myers Squibb Company

    • Table Product and Service Introduction of Bristol – Myers Squibb Company

    • Table Company Profile and Development Status of Sigma-Aldrich Co LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sigma-Aldrich Co LLC

    • Figure Sales and Growth Rate Analysis of Sigma-Aldrich Co LLC

    • Figure Revenue and Market Share Analysis of Sigma-Aldrich Co LLC

    • Table Product and Service Introduction of Sigma-Aldrich Co LLC

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of GenScript

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenScript

    • Figure Sales and Growth Rate Analysis of GenScript

    • Figure Revenue and Market Share Analysis of GenScript

    • Table Product and Service Introduction of GenScript

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Biogen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Inc

    • Figure Sales and Growth Rate Analysis of Biogen Inc

    • Figure Revenue and Market Share Analysis of Biogen Inc

    • Table Product and Service Introduction of Biogen Inc

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.